Kozak & Associates’s Ameriprise Financial AMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Buy
258
+1
+0.4% +$458 0.02% 94
2026
Q1
$117K Buy
257
+1
+0.4% +$482 0.02% 98
2025
Q4
$130K Buy
256
+1
+0.4% +$475 0.03% 91
2025
Q3
$113K Sell
255
-9
-3% -$4.61K 0.02% 107
2025
Q2
$142K Buy
264
+1
+0.4% +$494 0.03% 92
2025
Q1
$125K Buy
263
+1
+0.4% +$524 0.03% 92
2024
Q4
$140K Buy
262
+1
+0.4% +$534 0.03% 92
2024
Q3
$135K Hold
261
0.03% 94
2024
Q2
$113K Buy
261
+1
+0.4% +$427 0.03% 93
2024
Q1
$113K Sell
260
-68
-21% -$27.2K 0.03% 94
2023
Q4
$122K Buy
328
+1
+0.3% +$343 0.04% 92
2023
Q3
$107K Hold
327
0.04% 97
2023
Q2
$110K Hold
327
0.04% 100
2023
Q1
$100K Hold
327
0.05% 113
2022
Q4
$102K Hold
327
0.05% 106
2022
Q3
$87K Hold
327
0.05% 109
2022
Q2
$78K Hold
327
0.05% 123
2022
Q1
$89K Hold
327
0.06% 122
2021
Q4
$89K Hold
327
0.06% 122
2021
Q3
$101K Buy
+327
New +$85.5K 0.06% 114

Other funds holding AMP

Kozak & Associates's AMP Position: Q2 2026 in Review

Kozak & Associates increased its Ameriprise Financial (AMP) stake by 0.39% in Q2 2026, buying an estimated $458 and bringing the position to 258 shares worth $124K. The position accounts for 0.02% of the portfolio, ranked #94.

Kozak & Associates first reported a position in AMP in Q3 2021 and has held it in 20 quarters since. The position peaked at $142K in Q2 2025. 1,381 funds tracked by Wall St. Rank hold AMP as of Q2 2026.

  • Kozak & Associates held 258 shares of Ameriprise Financial worth $124K as of Q2 2026.
  • Kozak & Associates bought 1 Ameriprise Financial share in Q2 2026, an estimated $458.
  • Ameriprise Financial made up 0.02% of Kozak & Associates's portfolio in Q2 2026, its #94 holding.
  • Kozak & Associates first reported a position in Ameriprise Financial in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's Ameriprise Financial position peaked at $142K in Q2 2025.
  • 1,381 funds tracked by Wall St. Rank held Ameriprise Financial as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.